Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review-Reference-Cited by-同舟云学术

Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review

Published:2024-06-17 Issue:1 Volume: Page:20-30
ISSN:2588-0527
Container-title:Pharmacogenetics and Pharmacogenomics
language:
Short-container-title:Fgen_Fgenom

Author:

Nasyrova R. F.¹^ORCID,Kidyaeva A. V.²^ORCID,Grechkina V. V.³^ORCID,Shnayder N. A.⁴^ORCID

Affiliation:

1. FSBI V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology of the Russian Federation Ministry of Health; International Centre for Education and Research in Neuropsychiatry, FSBEI HE «Samara State Medical University» MOH Russia

2. FSBI V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology of the Russian Federation Ministry of Health; St. Petersburg State Psychiatric Hospital of St. Nicolas the Wonderwoker

3. FSBI V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology of the Russian Federation Ministry of Health

4. FSBI V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology of the Russian Federation Ministry of Health; Center for Collective Use, Molecular and Cellular Technologies, FSBEI НЕ “Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University” MOH Russia

Publisher

Publishing House OKI

Reference35 articles.

1. Rahman S, Marwaha R. Haloperidol. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 1, 2023.

2. Tavares J. Haloperidol's introduction in the United States: A tale of a failed trial and its consequences. J Hist Neurosci. 2024 Apr-Jun;33(2):169-179. doi: 10.1080/0964704X.2023.2283463.

3. Rognoni C, Bertolani A, Jommi C. Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and metaanalysis of metabolic and cardiovascular side effects. Clin Drug Investig. 2021;41(4):303-319. doi: 10.1007/s40261-021-01000-1

4. Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatry. 2021 Jul 19;11(7):355-364. doi: 10.5498/wjp.v11.i7.355.

5. Alamri AS, Alhomrani M, Alsanie WF, et al. Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a ChargeTransfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy. Molecules. 2022 May 20;27(10):3295. doi: 10.3390/molecules27103295.